Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.08.2020 | Case report

Fluorouracil/folinic acid/irinotecan

Various toxicities following an off-label treatment: 13 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Taghizadeh H, et al. First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer. Cancer Chemotherapy and Pharmacology 86: 109-115, No. 1, 2020. Available from: URL: http://doi.org/10.1007/s00280-020-04094-0 Taghizadeh H, et al. First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer. Cancer Chemotherapy and Pharmacology 86: 109-115, No. 1, 2020. Available from: URL: http://​doi.​org/​10.​1007/​s00280-020-04094-0
Metadaten
Titel
Fluorouracil/folinic acid/irinotecan
Various toxicities following an off-label treatment: 13 case reports
Publikationsdatum
01.08.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-81458-5

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Teriparatide

Case report

Clopidogrel

Case report

Sertraline